Results 11 to 20 of about 216,614 (305)
No reliable national antimicrobial consumption data have been available in Japan. The Japanese antimicrobial consumption surveillance (JACS) project started to collect data nationwide on antimicrobial consumption. This paper provides the first sales data from the JACS project on oral and parenteral antimicrobial consumption in Japan as well as the ...
Yuichi Muraki +10 more
openaire +4 more sources
Antimicrobial Drug Consumption in Companion Animals [PDF]
To the Editor: During the last decade, use of antimicrobial drugs for growth promotion and therapeutic treatment in food animals has received much attention. The reservoir of resistant bacteria in food animals implies a potential risk for transfer of resistant bacteria, or resistance genes, from food animals to humans.
Ole E. Heuer +2 more
openaire +3 more sources
Vancomycin-resistant enterococci infections are of great public health significance due to limited therapeutic options. We investigated epidemiological trends and risk factors of vancomycin resistance in enterococci isolates from patients with ...
Olaniyi Ayobami +4 more
doaj +1 more source
Trends of Inpatient Antibiotic Consumption in a Children’s Clinic
Introduction: Antimicrobials are the most commonly used medications among inpatient children. Moreover, a direct correlation exists between the magnitude of antibiotic consumption and the prevalence of resistant organisms.
Behçet ŞİMŞEK +3 more
doaj +1 more source
Background: The impact of antimicrobials generic entry (GE) is controversial. Their introduction could provide an economic benefit yet may also increase their consumption, leading to a higher risk of resistance. Our aim was to analyze the impact of GE on
Mercè Espona +7 more
doaj +1 more source
In contrast to food-producing animals, where the documentation of the usage of antimicrobials is regulated by law, antimicrobial usage (AMU) in dogs and cats is only sparsely monitored.
Anne Schnepf +4 more
doaj +1 more source
Introduction to the ESPAUR Webinar and Report 2021–2022: Key Findings and Stakeholder Engagement
During the coronavirus (COVID-19) pandemic, we saw significant decreases in the incidence of bloodstream infections (BSIs), antibiotic-resistant infections, and the burden of resistant infections.
Neil Cunningham +6 more
doaj +1 more source
This study aimed to clarify the relationship between carbapenem consumption and clinical outcome using the diagnosis procedure combination (DPC) payment system database (2020) published by the Ministry of Health, Labour, and Welfare of Japan.
Kozue Yamaguchi +3 more
doaj +1 more source
Background: Data on the benefits of rapid microbiological testing on antimicrobial consumption (AC) and antimicrobial resistance patterns (ARPs) are scarce.
Alejandro Rodríguez +19 more
doaj +1 more source
Analysis of the antibiotic consumption on the backdrop of the COVID-19 pandemic: hospital level
Introduction. According to available data, the frequency of prescribing antibacterial drugs to patients hospitalized with COVID-19 is many times higher than the level of bacterial infection recorded in them.
K. I. Karnoukh, N. B. Lazareva
doaj +1 more source

